Benscoter, Alexis L.
Alten, Jeffrey A.
Atreya, Mihir R.
Cooper, David S.
Byrnes, Jonathan W.
Nelson, David P.
Ollberding, Nicholas J.
Wong, Hector R.
Funding for this research was provided by:
National Institution of Health (R35GM126943)
Article History
Received: 17 January 2023
Accepted: 15 May 2023
First Online: 20 May 2023
Declarations
:
: This study was approved by the local IRB at Cincinnati Children’s Hospital Medical Center. The parents of minors provided consent for their child’s participation in this study, and, when applicable, assent was obtained from the study participant.
: The authors are deeply indebted to the contributions of senior author –Dr. Hector Wong (H.R.W). H.R.W. was involved in conceptualization and development of biomarker-based risk prediction models detailed in the manuscript with A.L.B. Due to his untimely death, H.R.W could not contribute to the final version of the manuscript. All other authors have reviewed the final manuscript and provided consent for publication.
: During the time of this study and manuscript preparation, H.R.W. and the Cincinnati Children’s Hospital Research Foundation hold US patents for the PERSEVERE biomarkers.